YHN Acquisition I Ltd

This filing provides critical updates on trust account status, business combination progress, redemption activity, and extension timeline. The 57.7% redemption rate and going concern warning indicate potential difficulty completing the deal. The trust value of $10.67 per share is above IPO price, but working capital deficit and reliance on sponsor advances raise liquidity concerns. The deadline is June 19, 2026; failure to close leads to liquidation.

Investors monitoring redemption calendars and sponsor behavior should note that the title update signifies reduced executive oversight during the unextended SEARCHING phase, while the disclosed execution price of $0.014 operates independently of the reported $10.98 trust reserve, indicating secondary market pricing dynamics rather than a shift in statutory trust accounting. Because the submission amends an earlier insider report, it rectifies historical regulatory timing without introducing structural modifications, preserving the integrity of the 2026-09-19 deadline and the existing trust framework for investor redemption modeling. The retained position of 15,000 shares confirms continued, albeit minimal, equity alignment without triggering additional disclosure thresholds.

This extension mechanically delays any mandatory redemption or liquidation trigger by exactly three months, shifting the active search phase past the original March expiration. The document contains no claims regarding target companies, revenue projections, market positioning, technological assets, commercial partnerships, litigation exposure, or personnel changes beyond the executive sign-off. Per the Company’s own disclosure, the filing serves strictly as a procedural notice of timeline adjustment. Investors should note that no per-share trust valuation was recalculated or re-stated in this filing, and all material assertions regarding the deposit and extended timeline originate solely from YHN Acquisition I Limited.

Third, regarding other substance, the registrant includes forward-looking statements warning that actual outcomes could differ materially from projected enterprise values, integration plans, or expected growth estimates. The filing attributes competitive risks to 'larger technology companies that have greater resources, technology, relationships and/or expertise,' and acknowledges a lack of useful financial information for estimating future capital expenditures or revenue until definitive filings are available. The extension to June 18, 2026 alters the final timeline for completing the dual-merger structure, which impacts the period during which shareholders may hold publicly traded securities awaiting a redemption decision. Because the earnout structure now depends entirely on public share price performance rather than operating metrics, the parties have realigned long-term compensation exposure away from commercial milestones. Without revised per-share trust accounting or specific redemption instructions in this submission, the filing primarily serves to synchronize the merger timeline while deferring precise investor liquidation mechanics to subsequent proxy and registration documents.

The extension alters the redemption and liquidation deadline, giving shareholders approximately three additional months before a mandatory vote or dissolution occurs. The deposit demonstrates sponsor commitment to continue searching for a target rather than liquidating immediately, which typically supports maintaining share value near trust levels during the extension period. The document contains no disclosures regarding customer metrics, revenue projections, market size, strategic partnerships, litigation, or personnel changes beyond the executive signatory.

The updated governance documents (Fourth Amended and Restated Memorandum and Articles of Association and the Amendment to the Investment Management Trust Agreement) codify the extended liquidation timeline, redefine the Termination Date, and specify the procedural requirements for extension letters, disbursement notices, and automatic redemption events. The quarterly $150,000 sponsorship deposits signal continued capital demands from insiders ahead of the revised deadline, while the tendering of over 3.4 million shares materially reduces the public float and trust corpus available for a future acquisition. Voting tallies show 3,769,814 shares cast FOR the charter amendment versus 2,729,472 AGAINST, and 3,405,776 FOR the trust amendment versus 3,093,510 AGAINST, highlighting shareholder分歧 on the extension plan. No claims regarding target customers, revenue, market size, or litigation appear in this filing.

Continuing the required sequence, the filing presents other substantive elements that affect capital allocation and strategic execution. The proposed amendments permanently alter the redemption timeline and preserve trust integrity during extensions, but failure to approve the measures or close the Mingde Technology Limited transaction by September 19, 2026 triggers automatic dissolution and pro-rata trust distribution. Strategic risk disclosures attribute the Company’s target pool limitations to U.S. foreign investment frameworks, noting that Pui Chun Wong exercises 100% voting power in YHN Partners I Limited, which exposes future combinations to potential CFIUS intervention or foreign ownership caps that could block or delay closings. Governance personnel disclosures confirm that independent directors Zhengming Feng, Donghui Xu, and Min Zhang collectively chair the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee, consolidating oversight responsibilities. Management simultaneously warns that because substantially all trust assets reside in money market funds invested primarily in U.S. Treasury Bills, prolonged extension periods increase the probability that regulators will classify the Company as an unregistered investment company under the Investment Company Act of 1940, a designation that would force abandonment of the business combination and trigger accelerated liquidation.

The filing updates the SPAC's financial health and deal progress. The reduced merger consideration ($280M vs original $396M) may indicate renegotiation pressures. Trust value per share ($10.50) provides a redemption floor. The December 18, 2025 deadline and going concern disclosure highlight urgency. Changes in management and sponsor advances signal ongoing operational activity.

This restructuring significantly shifts the deal's risk/reward profile and dilution mechanics for SPAC shareholders. By lowering the guaranteed upfront valuation from the previously disclosed $326,000,000 to $200,000,000, the deal implies a more conservative immediate valuation for the target while retaining the potential to reach $280,000,000 through equity-based earnouts. The pivot from revenue-based to price-based earnout triggers aligns the target's founders with supporting the surviving company's stock price post-combination, which may reduce selling pressure near or below the existing $10.98 trust/share floor. However, achieving $15.00, $20.00, or $25.00 requires substantial market appreciation within three years, meaning the full $80,000,000 earnout carries high execution risk. For redemption analysis, the amended terms mean fewer shares are locked in immediately, but the pathway to max payout is now entirely dependent on public market performance rather than private company revenue delivery. As stated in the filing, the aggregate maximum total Merger Consideration is Two Hundred Eighty Million Dollars ($280,000,000).

The extension framework replaces the imminent December 19, 2025 dissolution risk with a structured pathway to September 19, 2026, contingent on predictable $150,000 quarterly contributions that preserve remaining trust value. The sponsor loan structure signals insider commitment while creating a repayment obligation if the transaction closes. The $5,000,001 net tangible asset floor effectively caps the volume of shares that may be redeemed alongside the extension vote, forcing shareholders to compare open-market liquidity against the pro rata trust distribution. A dedicated section confirms the company executed a business combination agreement with Mingde Technology Limited on April 3, 2025, anchoring the SEARCHING status to a specific target. Management separately discloses foreign investment restrictions including CFIUS review, potential Investment Company Act classification risks, and a clawback policy adopted in July 2024. Redemption demands require written submission prior to 5:00 p.m. Eastern time two business days before the meeting, with physical or DTC electronic delivery required at least two business days in advance.

This filing confirms that insider equity and governance commitments were successfully transferred to the new CEO without altering the fundamental SPAC structure. By signing the Insider Letter, Ms. Poon contractually forfeits redemption rights for her holdings and accepts a strict 15-month deadline to either complete a business combination or trigger liquidation of the trust fund for public shareholders. The documented $214.29 per-transaction share transfer and escrow joinder verify continued sponsor lock-up compliance, while the explicit waiver of trust-account claims in the indemnification agreement limits potential insider recourse to post-combination entity funds or non-trust corporate assets, preserving the trust balance solely for public shareholder redemption or dissolution scenarios.

Per the filing, insider distribution by a former chief executive adjusts sponsor conduct metrics ahead of the 2026-09-19 redemption window. The documented trade price of $214.29 sits beside the stated trust value of $10.98, showing secondary market valuation exceeded net trust at the time of the transaction. The document discloses no target pipeline updates, customer assertions, revenue statements, technology roadmaps, strategic partnerships, or material litigation. Investors should monitor remaining insider positions as the deadline approaches, though this Form 4 neither modifies the redemption calendar, triggers an extension, nor changes the current trust composition.

This is the first filing containing the definitive deal terms and the target's business description since the letter of intent. Investors tracking the redemption deadline should note the trust per-share value of $10.40, the $1.5 million deferred underwriting fee, and the tight cash position. The filing states the combination period ends December 18, 2025, not the user-supplied date of 2026-09-19. The earnout structure and share issuance percentages are also new.

As YHN Acquisition I Ltd remains in SEARCHING status, this leadership transition alters the executive team responsible for sourcing and closing a business combination. According to the filing, Ms. Poon brings experience in mergers & acquisitions, US public listing advisory, corporate reorganization, fundraising, and over fifteen years of operational management beginning in February 2019. The registrant explicitly states that Mr. Tominaga’s departure was not caused by any disagreement relating to operations, policies, or practices. This submission reports zero amendments to the redemption calendar, trust mechanics, extension provisions, or sponsor conduct thresholds, leaving existing shareholder rights and the trust value of $10.98 per share unchanged relative to the September 19, 2026 deadline.

This filing provides the definitive terms for YHNA's proposed business combination with Mingde, including the new earnout structure that could significantly increase deal consideration and dilution for public shareholders. Shareholders evaluating redemption before the September 19, 2026 deadline now have a clearer picture of the deal economics, the performance targets for earnouts, and the sponsor's commitment (via a support agreement). The trust value ($10.98/share) exceeds the $10.00 per share consideration floor, providing context for redemption decisions.

Trust value per share is $10.29, below the prompt’s stated $10.98 – investors should use the filing’s $10.29 for redemption calculations. The December 18, 2025 deadline is fixed; the SPAC has ~7 months to close the Mingde deal. The definitive agreement provides a concrete valuation anchor ($396 million) and share exchange ratio (39.6 million shares at $10.00 per share), giving shareholders a basis to evaluate the pending merger. The company’s disclosure that it has not filed all required reports over the trailing 12 months and its going‑concern warning underscore execution risk. Sponsor advances and insider trading disclosures remain routine, with no red flags.

This filing does not amend the redemption calendar, extend the deadline, or adjust the trust account balance. It confirms mechanical progression toward closing while reiterating the registrant's explicit caution that there is currently a 'lack of useful financial information for an accurate estimate of future capital expenditures and future revenue.' The company identifies 'statements regarding Mingde’s industry and market size,' 'anticipated initial enterprise value,' 'potential level of redemptions,' and 'competition from larger companies' as forward-looking assertions subject to material uncertainty. Personnel identified in the execution block include CEO Satoshi Tominaga (Parent), Director Liu Lirong (Company), and Director Yangyujia An (both Purchaser and Merger Sub). Until the definitive proxy statement and registration statement are filed, redemption mechanics, pro forma valuation, and revenue projections remain unverified, making this filing a procedural checkpoint rather than a financial update for trust-value or vote-weight modeling.

This filing sets the deal economics and calendar for YHNA shareholders. It confirms the target, valuation, consideration structure, support agreements, and the key dates and conditions that determine whether a closing occurs before the Outside Date. Shareholders will get redemption rights in connection with the Parent Special Meeting, and the trust fund is represented to be at least $61,672,472 as of March 24, 2025. The no-termination-fee structure and the early termination right tied to the April 30, 2025 financial statement deadline are relevant to deal risk. The BCA also describes Mingde's business as operating online sports platforms and providing technological solutions for health product stores, with a VIE structure over Zhejiang Xiaojianren, and the closing is conditioned in part on a CSRC filing.

This filing definitively changes YHNA from a searching SPAC to one with a signed merger target, setting the terms for the business combination. The $396 million enterprise value, the $10.98 trust per share, and the requirement for audited financials by April 30, 2025, provide critical data for redemption and valuation decisions. The sponsor's commitment not to redeem and the PIPE target reduce the risk of insufficient trust proceeds. The deal is subject to shareholder approval, SEC effectiveness, CSRC filings, and other conditions. The agreement includes a no-shop clause and potential termination if financials are not delivered by April 30, 2025.

Confirms trust value per share ($10.18) and the 15-month deadline from IPO (December 18, 2025). The LOI indicates deal progress but the absence of a definitive agreement means uncertainty remains. The going concern disclosure highlights the risk of liquidation if a combination is not completed. Investors should monitor for a definitive agreement and potential redemption mechanics.

This moves the SPAC from a search posture into a specific target phase, triggering timeline monitoring for redemption voters despite not yet changing the official redemption calendar or extending the trust. The January 27, 2025 structural milestone and February 26, 2025 expiration provide concrete near-term dates to evaluate whether management will proceed toward a proxy statement. According to the LOI's own characterization of XJR, the target 'operates online sports platforms and provides technological solutions for health product stores.' The document notes that closing is contingent on due diligence, board approvals, and governmental/regulatory consents, while each party bears its own legal and advisor costs. No sponsor misconduct or unusual governance shifts are alleged; standard best-efforts and confidentiality obligations governed by New York law apply.

Registering a block exceeding 5% of the publicly traded class establishes a formal transparency threshold that recalibrates subsequent disclosure triggers, short-interest baselines, and proxy solicitation mathematics once a de-SPAC target is identified. Because Meteora Capital, LLC and Vik Mittal explicitly characterize the stake as passively managed, investors tracking redemption dynamics can model these units as portfolio-held inventory rather than conditional financing or activist commitments. The absence of merger milestones, extension proposals, or sponsor communications in this schedule leaves the issuer’s SEARCHING status and cash runway unaltered, though the disclosed 5.16% concentration represents a measurable vote weight that could affect shareholder approval ratios or inform tendering patterns during a future offer period.

Establishes baseline trust value, burn rate, and timeline for a freshly IPO'd SPAC. No material changes, but investors monitoring for extension or deal announcements later. Trust value slightly above $10.00 floor.

According to the filing, the trust holds $60,300,000 at par, establishing a documented starting redemption floor of $10.05 per share rather than importing standard market conventions. If the December 18, 2025 deadline expires, public shareholders will receive pro rata trust distributions while attached rights expire worthless and founder shares face forfeiture unless sponsors purchase additional public stock. The sponsor contractually warrants liability to indemnify the trust if third-party vendor claims reduce balances below $10.05 per share, subject to waiver agreements. Post-closing liquidity faces structural drains including a $10,000 per month administrative services payment to a sponsor affiliate for up to 15 months and a $260,303 promissory note fully repaid to the sponsor. The independent registered public accounting firm Adeptus Partners, LLC explicitly attached a 'Substantial Doubt about the Company’s Ability to Continue as a Going Concern' qualification, noting that missing the prescribed combination window will force operational cessation and liquidation, thereby quantifying execution risk for investors tracking trust preservation and extension viability.

What changed: Form 10-Q (Quarterly Report) for YHN Acquisition I Limited, a SPAC, for the period ended March 31, 2026, filed May 14, 2026. Trust account value increased from $27,050,906 to $27,438,949 due to $388,043 remeasurement and $150,000 extension deposit. Redemption price per share rose from $10.67 to $10.82. The company extended the business combination deadline to June 19, 2026 (two extensions used). Sponsor advances increased from $790,038 to $1,011,924. Working capital deficit widened to $984,667. Net income for Q1 2026 was $95,567. Company received Nasdaq deficiency notices on April 17, 2026 for MVPHS and MVLS non-compliance. The business combination agreement with Mingde Technology remains pending, with outside closing date extended to June 19, 2026. Why it matters: The trust value increase is positive but minimal; the company faces a rapidly approaching June 19, 2026 deadline to close the deal. Nasdaq listing is at risk, which could complicate the business combination. Sponsor support is critical as shown by rising advances. The going concern disclosure indicates substantial doubt if the deal fails. The redemption per share is above the IPO price, providing some protection for public shareholders.

What changed: Form 8-K Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 17, 2026, The Nasdaq Stock Market LLC issued two deficiency letters notifying YHN Acquisition I Limited that it failed to satisfy the minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 and the minimum Market Value of Listed Securities (MVLS) of $50,000,000 for 30 consecutive business days spanning March 5, 2026, to April 16, 2026. Nasdaq granted the company a 180-calendar-day cure period expiring October 14, 2026. To regain compliance, the company must demonstrate an MVPHS closing at $15,000,000 or more, or an MVLS closing at $50,000,000 or more, for a minimum of 10 consecutive business days before that deadline. As of April 20, 2026, Ordinary Shares will continue trading on Nasdaq under the symbol “YHNA” without immediate effect. Why it matters: This filing does not alter the SPAC’s September 19, 2026, redemption deadline, the reported $10.98 trust value per share, or the ongoing SEARCHING status. However, the simultaneous MVPHS and MVLS deficiencies signal sustained low capitalization, which can constrict secondary market liquidity and complicate shareholder exit pathways independent of a redemption event. Chief Executive Officer Poon Man Ka, Christy signed the filing to disclose that the registrant ‘will consider implementing available options to regain compliance’ and ‘intends to monitor’ the Nasdaq requirements. If the company cannot restore either threshold by October 14, 2026, Nasdaq will issue a formal delisting notice, though the filing notes a potential alternative path via transfer to The Nasdaq Capital Market subject to a separate online application and satisfaction of Capital Market continued listing requirements.

What changed: Routine compliance exhibit — a Schedule 13G/A beneficial ownership report. The filing identifies RiverNorth Capital Management, LLC as the reporting holder. The provided text lists only the document designation, accession number, and holder name. It contains no share counts, percentages, acquisition dates, or voting/investment authority designations. It makes no reference to redemption mechanics, trust account distributions, extension proposals, target identification, or sponsor conduct. Why it matters: Institutional ownership filings track capital concentration and can foreshadow proxy activity or merger negotiations, but this excerpt supplies zero quantitative holdings or strategic directives. According to the filing text, RiverNorth Capital Management, LLC reports solely as a holding entity without advancing claims about customer relationships, revenue composition, market sizing, corporate strategy, technology development, partnership structures, pending litigation, or personnel appointments. Because it discloses neither aggregate position nor transaction timestamps, it does not signal shareholder activism, redemption expectations, or challenges to sponsor behavior ahead of the scheduled search expiration. Material impact would require subsequent amendments specifying share changes or voting intent.

What changed: A Form 4/A amendment to an insider ownership report, classified as a routine compliance exhibit used to correct or supplement previously filed Section 16 disclosures by reporting person Tominaga Satoshi. Bearing on the mechanics you track, the amended filing does not modify the documented SEARCHING status, the $10.98 trust/share ledger balance, or the 2026-09-19 liquidation deadline. It contains no notices regarding extension resolutions, redemption window calculations, target discovery, or deal progress. Instead, the report discloses that Tominaga Satoshi executed an open-market sale on 2025-08-01, disposing of 15,000 shares at $0.014 per share, leaving a confirmed post-transaction holding of 15,000 shares. The reporting person labels himself as “Former CEO and Director,” which updates the issuer’s executive roster without explaining the departure rationale, successor arrangements, or sponsor conduct details. No substantive claims regarding customer bases, revenue streams, addressable markets, strategic pivots, proprietary technology, partnership agreements, or active litigation appear in the disclosure. Why it matters: Investors monitoring redemption calendars and sponsor behavior should note that the title update signifies reduced executive oversight during the unextended SEARCHING phase, while the disclosed execution price of $0.014 operates independently of the reported $10.98 trust reserve, indicating secondary market pricing dynamics rather than a shift in statutory trust accounting. Because the submission amends an earlier insider report, it rectifies historical regulatory timing without introducing structural modifications, preserving the integrity of the 2026-09-19 deadline and the existing trust framework for investor redemption modeling. The retained position of 15,000 shares confirms continued, albeit minimal, equity alignment without triggering additional disclosure thresholds.

What changed: Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed by YHN Acquisition I Limited (YHNA), a blank check SPAC that has entered into a business combination agreement with Mingde Technology Limited. First annual report since IPO (Sept 2024). Key changes: (1) Entered binding business combination agreement with Mingde Technology Limited (online sports platform) in April 2025, amended multiple times to restructure consideration ($200M base plus up to $80M earnout). (2) At December 2025 shareholder meeting, 3,464,179 shares redeemed for $36.65M, reducing trust from $61.1M to $27.1M. Trust per-share value rose to $10.67 from $10.18 due to redemptions and interest. (3) Extension approved to September 19, 2026 (three possible 3-month extensions). Two extensions used so far, current deadline June 19, 2026. (4) Working capital deficit of $692,191; cash $140,550; sponsor advance $790,038. (5) Net income of $1.33M (2025) vs $0.50M (2024) from trust interest/dividends. (6) Going concern warning if business combination not completed by deadline. Why it matters: This filing provides critical updates on trust account status, business combination progress, redemption activity, and extension timeline. The 57.7% redemption rate and going concern warning indicate potential difficulty completing the deal. The trust value of $10.67 per share is above IPO price, but working capital deficit and reliance on sponsor advances raise liquidity concerns. The deadline is June 19, 2026; failure to close leads to liquidation.

What changed: Form 8-K Current Report under Item 8.01, disclosing a voluntary capital contribution to extend the SPAC’s business combination period. According to YHN Acquisition I Limited, on March 19, 2026 the Company deposited $150,000 into its trust account. As stated in the filing and attested by Chief Executive Officer Poon Man Ka, Christy, this deposit extends the deadline to complete a business combination from March 19, 2026 to June 19, 2026. Why it matters: This extension mechanically delays any mandatory redemption or liquidation trigger by exactly three months, shifting the active search phase past the original March expiration. The document contains no claims regarding target companies, revenue projections, market positioning, technological assets, commercial partnerships, litigation exposure, or personnel changes beyond the executive sign-off. Per the Company’s own disclosure, the filing serves strictly as a procedural notice of timeline adjustment. Investors should note that no per-share trust valuation was recalculated or re-stated in this filing, and all material assertions regarding the deposit and extended timeline originate solely from YHN Acquisition I Limited.

What changed: SEC Schedule 13G/A beneficial ownership amendment filed by Westchester Capital Management, LLC. This document identifies Westchester Capital Management, LLC as the reporting holder and contains no updates bearing on redemption deadlines, trust value, extension procedures, target acquisition progress, or sponsor conduct. It makes no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel attributable to management, sponsors, or any other party. Why it matters: As a standard regulatory submission, this filing does not alter the SPAC’s $10.98 per-share trust balance, its 2026-09-19 business combination deadline, or its SEARCHING status. Without new operational disclosures or transactional milestones, investors should continue relying on prior prospectus and proxy materials for redemption parameters, timeline expectations, and potential sponsor actions.

What changed: This document consists of two Limited Powers of Attorney (Exhibit A and Exhibit B) executed by authorized corporate representatives to delegate statutory Form 13G execution, amendment, and filing authority to designated attorneys-in-fact. The provided text contains no updates to YHN Acquisition I Ltd’s redemption mechanics, trust accounting, search deadline, target acquisition trajectory, or sponsor governance. Instead, Hidekatsu Take (Deputy President & Corporate Executive of Mizuho Financial Group, Inc.; Managing Executive Officer of Mizuho Bank, Ltd.) and Adam Hopkins (Chief Legal Officer and Managing Director, General Counsel of Mizuho Americas LLC and Mizuho Securities USA LLC) formally grant Takahiro Katsura (Managing Director, Head of Global Branches & Subsidiaries Coordination Office, Global Corporate Function Coordination Department of Mizuho Financial Group, Inc.) limited power under Section 13(d) and Section 13(g) of the Securities Exchange Act of 1934 to complete, execute, and timely submit Form 13G filings and amendments. Exhibit A catalogues the principal business offices for three affiliated entities, listing “1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan” and “1271 Avenue of the Americas, NY, NY 10020, USA”, with all execution dates recorded as 2-12-2026. Why it matters: Because the instrument functions exclusively as an administrative proxy for U.S. equity ownership reporting compliance, it does not alter shareholder redemption windows, impact the per-share trust valuation, modify the organizational extension timeline, signal target negotiation progress, or reflect shifts in sponsor fiduciary conduct or capital deployment strategy. The delegation merely confirms Mizuho-linked entities maintain standardized regulatory representation capacity for future 13G disclosures, carrying no standalone implication for liquidity events, conversion ratios, or business combination execution.

What changed: A Schedule 13G/A, which is a routine SEC compliance exhibit filed to amend a previously submitted beneficial ownership report when a reporting person’s stake exceeds five percent of a class of equity securities. The provided excerpt identifies W. R. Berkley Corporation and Berkley Insurance Company as the reporting holders but contains no numerical data, percentage shifts, acquisition dates, or stated purposes for acquisition. No movement is reported that impacts YHNA’s redemption deadline mechanics, trust account valuation, extension voting timeline, target search progress, or sponsor fiduciary conduct. Why it matters: Schedule 13G/A amendments maintain the public register of major shareholders once the five percent threshold is crossed or adjusted. The absence of qualitative purpose statements or quantitative delta disclosures in this excerpt indicates passive indexing maintenance rather than activist accumulation or coordinated voting intent ahead of the 2026-09-19 expiration. For SPAC tracking, this filing does not alter redemption expectations, nor does it signal sponsor concessions or trust distribution triggers; investors must await a complete amendment, proxy statement, or business combination announcement to evaluate actual capital commitment or extension mechanics.

What changed: A routine compliance exhibit — specifically a Joint Filing Agreement attached to a Schedule 13G/A, executed under Rule 13d-1(k) of the Securities Exchange Act of 1934. Feis Equities LLC and Lawrence M. Feis executed the agreement on January 30, 2026, consenting to file jointly on behalf of their previously submitted Schedule 13G regarding ordinary shares of YHN Acquisition I Limited. The exhibit introduces no amendments to beneficial ownership thresholds, no new contractual obligations, and no corporate or financing actions. Why it matters: As a procedural regulatory attachment, this agreement does not alter redemption deadlines, shift trust value distributions, activate extension periods, advance deal progress, or reflect changes in sponsor conduct. The text contains zero disclosures regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; all statements are strictly limited to the signatories’ mutual authorization to utilize the joint filing mechanism for federal securities reporting. Because it addresses only shared regulatory administrative logistics, it bears no material bearing on investor redemption calculus or SPAC operational timelines.